Wang CC, et al. - The mutation status of the TERT promoter, FGFR3 gene, and HRAS gene was comprehensively contemplated by the authors, in the case of low-grade papillary urothelial neoplasms. Additionally, an assessment was conducted of their prognostic significance. It was deduced that the status of the TERT promoter mutation could present as a biomarker of prognostic stratification in patients with papillary urothelial neoplasm of low malignant potential (PUNLMP).